Analyst Consensus ?
ConsensusBuy55 ratings
Bullish3869.1%
Neutral1221.8%
Bearish59.1%
FN2 Earnings Intelligence
The Boeing Company (BA) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 26, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 19, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 15, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Oct 12, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 9, 2026 |
| Jefferies | Buy | Buy | Maintain | Sep 21, 2026 |
| B of A Securities | Buy | Buy | Maintain | Sep 18, 2026 |
| Argus Research | Buy | Hold | Upgrade | Aug 11, 2026 |
| Tigress Financial | Buy | Buy | Maintain | Aug 6, 2026 |
| BNP Paribas | Outperform | Underperform | Upgrade | Aug 3, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 29, 2026 |
| Citigroup | Buy | Buy | Maintain | May 18, 2026 |
| Freedom Broker | Buy | Buy | Maintain | Feb 6, 2026 |
| UBS | Buy | Buy | Maintain | Jan 28, 2026 |
| Susquehanna | Positive | Positive | Maintain | Nov 12, 2025 |
| Freedom Capital Markets | Buy | Hold | Upgrade | Nov 3, 2025 |
| Vertical Research | Buy | Hold | Upgrade | Sep 8, 2025 |
| Barclays | Overweight | Overweight | Maintain | Jul 29, 2025 |
| Redburn Atlantic | Buy | Neutral | Upgrade | Jun 27, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Jun 12, 2025 |
| Wells Fargo | Underweight | Underweight | Maintain | Apr 24, 2025 |
| TD Securities | Buy | Buy | Maintain | Apr 24, 2025 |
| Benchmark | Buy | Buy | Maintain | Apr 21, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Jan 2, 2025 |
| Baird | Outperform | Outperform | Maintain | Oct 24, 2024 |
| Stifel | Buy | Buy | Maintain | Aug 1, 2024 |
| Northcoast Research | Sell | Neutral | Downgrade | Apr 17, 2024 |
| Melius Research | Hold | Buy | Downgrade | Apr 1, 2024 |
| Wolfe Research | Outperform | Outperform | Maintain | Mar 13, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 27, 2023 |
| Redburn Partners | Neutral | Neutral | Maintain | Nov 7, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Mar 7, 2022 |
| Berenberg | Hold | Hold | Maintain | Jun 15, 2021 |
| Canaccord Genuity | Buy | Hold | Upgrade | Mar 5, 2021 |
| Redburn | Sell | Neutral | Downgrade | Dec 17, 2020 |
| Alembic Global | Overweight | Neutral | Upgrade | Sep 28, 2020 |
| Seaport Global | Buy | Buy | Maintain | Jun 8, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Feb 5, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Feb 5, 2020 |
| CFRA | Buy | Hold | Upgrade | Jan 22, 2020 |
| Longbow Research | Underperform | Underperform | Maintain | Jan 7, 2020 |
| Bank of America | Neutral | Neutral | Maintain | Dec 23, 2019 |
| Citi | Buy | Buy | Maintain | Oct 24, 2019 |
| Argus | Hold | Buy | Downgrade | Mar 19, 2019 |
| Societe Generale | Buy | Hold | Upgrade | Apr 26, 2018 |
| Edward Jones | Buy | Hold | Upgrade | Feb 13, 2018 |
| Standpoint Research | Sell | Buy | Downgrade | Oct 26, 2016 |
| Stifel Nicolaus | Buy | Buy | Maintain | Feb 23, 2015 |
| Drexel Hamilton | Buy | Hold | Upgrade | May 22, 2014 |
| CRT Capital | Buy | Buy | Maintain | Feb 6, 2014 |
| Oppenheimer | Perform | Outperform | Downgrade | Nov 20, 2013 |
| Sterne Agee | Buy | Buy | Maintain | Sep 16, 2013 |
| Imperial Capital | In Line | In Line | Maintain | May 24, 2013 |
| BB&T Capital | Buy | Hold | Upgrade | Apr 26, 2013 |
| Early Bird Capital | Buy | Buy | Maintain | Jul 25, 2012 |
| DA Davidson | Neutral | Neutral | Maintain | Jul 25, 2012 |
Upside is calculated against the persisted current price $188.31. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Kristine Liwag | $225 | $188.73 | +19.5% | Oct 16, 2026 |
| RBC Capital | Analyst unavailable | $235 | $184.45 | +24.8% | Oct 15, 2026 |
| Bernstein | Analyst unavailable | $278 | $190.37 | +47.6% | Oct 12, 2026 |
| Barclays | Anthony Valentini | $300 | $187.75 | +59.3% | Oct 8, 2026 |
| Jefferies | Analyst unavailable | $265 | $200.76 | +40.7% | Sep 21, 2026 |
| Argus Research | Analyst unavailable | $265 | $232.79 | +40.7% | Aug 11, 2026 |
| Tigress Financial | Ivan Feinseth | $305 | $234.28 | +62.0% | Aug 6, 2026 |
| RBC Capital | Analyst unavailable | $265 | $212.4 | +40.7% | Jul 29, 2026 |
| Robert W. Baird | Peter Arment | $300 | $221.56 | +59.3% | Jul 29, 2026 |
| BTG Pactual | Analyst unavailable | $260 | $217.11 | +38.1% | Jul 14, 2026 |
| Tigress Financial | Analyst unavailable | $295 | $222.22 | +56.7% | Apr 29, 2026 |
| Wolfe Research | Analyst unavailable | $275 | $233.86 | +46.0% | Apr 23, 2026 |
| Morgan Stanley | Analyst unavailable | $250 | $233.66 | +32.8% | Apr 23, 2026 |
| Jefferies | Analyst unavailable | $295 | $233.72 | +56.7% | Feb 1, 2026 |
| RBC Capital | Ken Herbert | $275 | $241.42 | +46.0% | Jan 28, 2026 |
| Morgan Stanley | Analyst unavailable | $245 | $240.54 | +30.1% | Jan 28, 2026 |
| UBS | Gavin Parsons | $285 | $244.56 | +51.3% | Jan 28, 2026 |
| Vertical Research | Robert Stallard | $281 | $244.56 | +49.2% | Jan 27, 2026 |
| Susquehanna | Analyst unavailable | $280 | $247.24 | +48.7% | Jan 15, 2026 |
| Bernstein | Douglas Harned | $298 | $242.61 | +58.2% | Jan 15, 2026 |
| Bernstein | Analyst unavailable | $277 | $230.02 | +47.1% | Jan 6, 2026 |
| Tigress Financial | Analyst unavailable | $275 | $216.21 | +46.0% | Dec 29, 2025 |
| New Street | Analyst unavailable | $257 | $200.54 | +36.5% | Dec 9, 2025 |
| BNP Paribas | Analyst unavailable | $150 | $189.63 | -20.3% | Nov 18, 2025 |
| Bernstein | Douglas Harned | $267 | $194.85 | +41.8% | Nov 14, 2025 |
| Susquehanna | Analyst unavailable | $255 | $195.21 | +35.4% | Nov 12, 2025 |
| Loop Capital Markets | Sergey Glinyanov | $223 | $201.02 | +18.4% | Nov 3, 2025 |
| UBS | Analyst unavailable | $275 | $213.58 | +46.0% | Oct 30, 2025 |
| Jefferies | Analyst unavailable | $255 | $215.81 | +35.4% | Sep 30, 2025 |
| Vertical Research | Robert Stallard | $270 | $230.53 | +43.4% | Sep 8, 2025 |
| UBS | Analyst unavailable | $280 | $225.84 | +48.7% | Jul 30, 2025 |
| Barclays | Analyst unavailable | $255 | $226.08 | +35.4% | Jul 29, 2025 |
| RBC Capital | Ken Herbert | $230 | $203.75 | +22.1% | Jun 12, 2025 |
| Morgan Stanley | Kristine Liwag | $200 | $203.75 | +6.2% | Jun 12, 2025 |
| Goldman Sachs | Noah Poponak | $212 | $214 | +12.6% | Jun 11, 2025 |
| Melius Research | Analyst unavailable | $204 | $180.9 | +8.3% | Mar 24, 2025 |
| Deutsche Bank | Scott Deuschle | $215 | $171.87 | +14.2% | Jan 2, 2025 |
| Bernstein | Douglas Harned | $169 | $152.98 | -10.3% | Oct 29, 2024 |
| Susquehanna | Charles Minervino | $200 | $157.06 | +6.2% | Oct 24, 2024 |
| Robert W. Baird | Peter Arment | $200 | $157.06 | +6.2% | Oct 24, 2024 |
| J.P. Morgan | Seth Seifman | $195 | $159.88 | +3.6% | Oct 23, 2024 |
| Citigroup | Jason Gursky | $209 | $148.99 | +11.0% | Oct 15, 2024 |
| Deutsche Bank | Scott Deuschle | $195 | $152.89 | +3.6% | Oct 3, 2024 |
| Wolfe Research | Myles Walton | $210 | $156.3 | +11.5% | Sep 24, 2024 |
| Goldman Sachs | Noah Poponak | $202 | $156.3 | +7.3% | Sep 24, 2024 |
| Jefferies | Sheila Kahyaoglu | $240 | $153.29 | +27.4% | Sep 23, 2024 |
| Citigroup | Jason Gursky | $224 | $156.77 | +19.0% | Sep 16, 2024 |
| CFRA | Stewart Glickman | $151 | $156.77 | -19.8% | Sep 13, 2024 |
| Wolfe Research | Myles Walton | $215 | $162.77 | +14.2% | Sep 13, 2024 |
| Goldman Sachs | Noah Poponak | $232 | $161.02 | +23.2% | Sep 3, 2024 |
| Wells Fargo | Matthew Akers | $119 | $173.74 | -36.8% | Sep 3, 2024 |
| Bank of America Securities | Ronald Epstein | $200 | $174.96 | +6.2% | Aug 26, 2024 |
| Seaport Global | Richard Safran | $207 | $174.73 | +9.9% | Aug 23, 2024 |
| Bernstein | Douglas Harned | $207 | $169.95 | +9.9% | Aug 5, 2024 |
| UBS | Gavin Parsons | $240 | $191.42 | +27.4% | Jun 7, 2024 |
| Robert W. Baird | Peter Arment | $240 | $177.61 | +27.4% | Jun 3, 2024 |
| Barclays | David Strauss | $190 | $177.61 | +0.9% | Jun 3, 2024 |
| Bernstein | Douglas Harned | $215 | $177.61 | +14.2% | Jun 3, 2024 |
| Stifel Nicolaus | Bert Subin | $230 | $172.21 | +22.1% | May 23, 2024 |
| CFRA | Stewart Glickman | $147 | $172.21 | -21.9% | May 23, 2024 |
| Wolfe Research | Myles Walton | $220 | $174.33 | +16.8% | May 23, 2024 |
| Deutsche Bank | Scott Deuschle | $225 | $162.98 | +19.5% | Apr 25, 2024 |
| Goldman Sachs | Noah Poponak | $243 | $164.33 | +29.0% | Apr 25, 2024 |
| Stifel Nicolaus | Bert Subin | $240 | $164.33 | +27.4% | Apr 24, 2024 |
| Northcoast Research | Chris Olin | $140 | $170.55 | -25.7% | Apr 17, 2024 |
| RBC Capital | Ken Herbert | $215 | $167.82 | +14.2% | Apr 16, 2024 |
| Morgan Stanley | Kristine Liwag | $180 | $178.12 | -4.4% | Apr 10, 2024 |
| Stifel Nicolaus | Bert Subin | $260 | $178.12 | +38.1% | Apr 9, 2024 |
| Bernstein | Douglas Harned | $240 | $183.14 | +27.4% | Apr 8, 2024 |
| Jefferies | Analyst unavailable | $85 | $184.92 | -54.9% | Apr 3, 2024 |
| CFRA | Analyst unavailable | $164 | $191.95 | -12.9% | Mar 28, 2024 |
| UBS | Gavin Parsons | $250 | $191.41 | +32.8% | Mar 25, 2024 |
| Morgan Stanley | Kristine Liwag | $235 | $191.41 | +24.8% | Mar 25, 2024 |
| Vertical Research | Robert Stallard | $230 | $191.41 | +22.1% | Mar 25, 2024 |
| Susquehanna | Charles Minervino | $230 | $187.7 | +22.1% | Mar 21, 2024 |
| Barclays | David Strauss | $235 | $187.7 | +24.8% | Mar 21, 2024 |
| Deutsche Bank | Scott Deuschle | $240 | $187.7 | +27.4% | Mar 21, 2024 |
| Wolfe Research | Myles Walton | $260 | $182.35 | +38.1% | Mar 13, 2024 |
| RBC Capital | Ken Herbert | $260 | $184.24 | +38.1% | Mar 12, 2024 |
| Jefferies | Shelia Kahyaoglu | $300 | $184.24 | +59.3% | Mar 12, 2024 |
| Susquehanna | Charles Minervino | $279 | $200.44 | +48.2% | Jan 31, 2024 |
| Deutsche Bank | Scott Deuschle | $270 | $217.71 | +43.4% | Nov 20, 2023 |
| Susquehanna | Charles Minervino | $270 | $209.76 | +43.4% | Sep 13, 2023 |
| Credit Suisse | Scott Deuschle | $220 | $210.26 | +16.8% | Apr 10, 2023 |
| RBC Capital | Ken Herbert | $225 | $207.09 | +19.5% | Feb 3, 2023 |
| Wells Fargo | Analyst unavailable | $240 | $206.69 | +27.4% | Jan 11, 2023 |
| J.P. Morgan | Analyst unavailable | $207 | $206.69 | +9.9% | Jan 11, 2023 |
| Morgan Stanley | Kristine Liwag | $220 | $208.57 | +16.8% | Jan 10, 2023 |
| J.P. Morgan | Analyst unavailable | $200 | $183.74 | +6.2% | Dec 12, 2022 |
| Wells Fargo | Analyst unavailable | $218 | $180.91 | +15.8% | Dec 8, 2022 |
| RBC Capital | Ken Herbert | $170 | $156.75 | -9.7% | Nov 3, 2022 |
| New Street | Sam Boughedda Ahead | $175 | $131.57 | -7.1% | Oct 11, 2022 |
| Morgan Stanley | Kristine Liwag | $233 | $127.51 | +23.7% | Sep 27, 2022 |
| Goldman Sachs | Noah Poponak | $281 | $169.87 | +49.2% | Aug 1, 2022 |
| Wells Fargo | Analyst unavailable | $210 | $156.09 | +11.5% | Jul 28, 2022 |
| RBC Capital | Ken Herbert | $200 | $144.66 | +6.2% | Jul 14, 2022 |
| RBC Capital | Analyst unavailable | $200 | $144.18 | +6.2% | Jul 14, 2022 |
| J.P. Morgan | Analyst unavailable | $188 | $143.09 | -0.2% | Jul 13, 2022 |
| Morgan Stanley | Kristine Liwag | $215 | $120.7 | +14.2% | May 22, 2022 |
| Susquehanna | Charles Minervino | $192 | $120.7 | +2.0% | May 21, 2022 |
| Vertical Research | Robert Stallard | $193 | $127.2 | +2.5% | May 15, 2022 |
| RBC Capital | Ken Herbert | $220 | $148.84 | +16.8% | May 1, 2022 |
| Robert W. Baird | Peter Arment | $245 | $148.84 | +30.1% | Apr 30, 2022 |
| Bernstein | Douglas Harned | $216 | $154.22 | +14.7% | Apr 29, 2022 |
| J.P. Morgan | Analyst unavailable | $190 | $152.22 | +0.9% | Apr 28, 2022 |
| Susquehanna | Analyst unavailable | $193 | $152.72 | +2.5% | Apr 28, 2022 |
| Wells Fargo | Analyst unavailable | $214 | $152.47 | +13.6% | Apr 28, 2022 |
| Cowen & Co. | Cai von Rumohr | $230 | $154.46 | +22.1% | Apr 28, 2022 |
| Vertical Research | Robert Stallard | $198 | $154.46 | +5.1% | Apr 27, 2022 |
| Benchmark Co. | Josh Sullivan | $250 | $171.05 | +32.8% | Apr 26, 2022 |
| Morgan Stanley | Kristine Liwag | $230 | $175.03 | +22.1% | Apr 11, 2022 |
| Robert W. Baird | Peter Arment | $306 | $192.83 | +62.5% | Mar 20, 2022 |
| Goldman Sachs | Noah Poponak | $307 | $178.39 | +63.0% | Mar 10, 2022 |
| Jefferies | Sheila Kahyaoglu | $270 | $206.45 | +43.4% | Feb 6, 2022 |
| Argus Research | John Eade | $210 | $200.24 | +11.5% | Jan 31, 2022 |
| Morgan Stanley | Kristine Liwag | $288 | $190.57 | +52.9% | Jan 29, 2022 |
| Wells Fargo | Matthew Akers | $250 | $189.75 | +32.8% | Jan 27, 2022 |
| Vertical Research | Robert Stallard | $234 | $194.27 | +24.3% | Jan 26, 2022 |
| Citigroup | Charles Armitage | $238 | $214.19 | +26.4% | Jan 20, 2022 |
| Bernstein | Douglas Harned | $259 | $225.01 | +37.5% | Jan 18, 2022 |
| Barclays | David E. Strauss | $225 | $211.34 | +19.5% | Jan 6, 2022 |
| Susquehanna | Charles Minervino | $243 | $211.34 | +29.0% | Jan 6, 2022 |
| Seaport Global | Richard Safran | $298 | $209.9 | +58.2% | Nov 22, 2021 |
| Credit Suisse | Robert Spingarn | $265 | $217.15 | +40.7% | Jul 20, 2021 |
| Capital One Financial | Jonathan Raviv | $240 | $234.82 | +27.4% | May 21, 2021 |
Track every rating change on BA the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.